A Five-Gene-Pair-Based Prognostic Signature for Predicting the Relapse Risk of Early Stage ER+ Breast Cancer

About 20–30% of early-stage breast cancer patients suffer relapses after surgery. To identify such high-risk patients, many signatures have been reported, but they lack robustness in data measured on different platforms. Here, we developed a signature which is robust across multiple profiling platfo...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Na, Cai, Hao, Song, Kai, Guo, You, Liang, Qirui, Zhang, Jiahui, Chen, Rou, Li, Jing, Wang, Xianlong, Guo, Zheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Genetics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7658391/
https://www.ncbi.nlm.nih.gov/pubmed/33193655
http://dx.doi.org/10.3389/fgene.2020.566928

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7658391/
https://www.ncbi.nlm.nih.gov/pubmed/33193655
http://dx.doi.org/10.3389/fgene.2020.566928

Ejemplares similares